Nitric Oxide for Cancer Therapy | Zendy

Sergio Huerta | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nitric Oxide for Cancer Therapy

Author(s) -

Sergio Huerta

Publication year - 2015

Publication title -

future science oa

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.825

H-Index - 23

ISSN - 2056-5623

DOI - 10.4155/fso.15.44

Subject(s) - cancer , nitric oxide , medicine , cancer therapy , pharmacology , cancer cell , cancer treatment , cancer research

Resistance to current therapeutic interventions is a major challenge in the treatment of patients affected by cancer. While nitric oxide (NO) might have proneoplastic properties, it is now clear that at high doses, NO has a role in cancer therapeutics. Either as a single agent or in combination with other antineoplastic compounds, NO might be used to overcome tumor cell resistance to conventional treatments. The following discussion addresses the role of NO in cancer therapeutics and includes a report on the role of NO donors in the area of cancer therapeutics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research